State Street’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-127,282
| Closed | -$1.9M | – | 4922 |
|
|
2022
Q4 | $1.9M | Buy |
127,282
+29,593
| +30% | +$410K | ﹤0.01% | 3384 |
|
|
2022
Q3 | $804K | Buy |
97,689
+600
| +0.6% | +$4.61K | ﹤0.01% | 3646 |
|
|
2022
Q2 | $637K | Hold |
97,089
| – | – | ﹤0.01% | 3741 |
|
|
2022
Q1 | $543K | Buy |
97,089
+8,194
| +9% | +$33.8K | ﹤0.01% | 4019 |
|
|
2021
Q4 | $417K | Hold |
88,895
| – | – | ﹤0.01% | 4089 |
|
|
2021
Q3 | $549K | Sell |
88,895
-7,100
| -7% | -$42.5K | ﹤0.01% | 3937 |
|
|
2021
Q2 | $633K | Sell |
95,995
-219,192
| -70% | -$1.51M | ﹤0.01% | 3777 |
|
|
2021
Q1 | $2.31M | Buy |
315,187
+36,920
| +13% | +$319K | ﹤0.01% | 3378 |
|
|
2020
Q4 | $1.61M | Buy |
278,267
+87,333
| +46% | +$500K | ﹤0.01% | 3443 |
|
|
2020
Q3 | $1.13M | Buy |
190,934
+59,424
| +45% | +$294K | ﹤0.01% | 3401 |
|
|
2020
Q2 | $677K | Buy |
+131,510
| New | +$830K | ﹤0.01% | 3497 |
|
|
2020
Q1 | – | Sell |
-7,961
| Closed | -$50K | – | 3821 |
|
|
2019
Q4 | $50K | Hold |
7,961
| – | – | ﹤0.01% | 3724 |
|
|
2019
Q3 | $67K | Hold |
7,961
| – | – | ﹤0.01% | 3699 |
|
|
2019
Q2 | $54K | Sell |
7,961
-173,390
| -96% | -$1.49M | ﹤0.01% | 3716 |
|
|
2019
Q1 | $1.49M | Buy |
181,351
+6,595
| +4% | +$68.1K | ﹤0.01% | 3251 |
|
|
2018
Q4 | $2.8M | Buy |
174,756
+14,670
| +9% | +$323K | ﹤0.01% | 2988 |
|
|
2018
Q3 | $5.3M | Buy |
160,086
+4,095
| +3% | +$105K | ﹤0.01% | 2837 |
|
|
2018
Q2 | $3.53M | Buy |
155,991
+141,857
| +1,004% | +$3.36M | ﹤0.01% | 3029 |
|
|
2018
Q1 | $410K | Buy |
14,134
+1,420
| +11% | +$41.5K | ﹤0.01% | 3461 |
|
|
2017
Q4 | $355K | Buy |
12,714
+3,476
| +38% | +$108K | ﹤0.01% | 3496 |
|
|
2017
Q3 | $336K | Buy |
9,238
+6,700
| +264% | +$207K | ﹤0.01% | 3532 |
|
|
2017
Q2 | $57K | Hold |
2,538
| – | – | ﹤0.01% | 3587 |
|
|
2017
Q1 | $15K | Hold |
2,538
| – | – | ﹤0.01% | 3631 |
|
|
2016
Q4 | $14K | Hold |
2,538
| – | – | ﹤0.01% | 3626 |
|
|
2016
Q3 | $22K | Hold |
2,538
| – | – | ﹤0.01% | 3531 |
|
|
2016
Q2 | $25K | Hold |
2,538
| – | – | ﹤0.01% | 3639 |
|
|
2016
Q1 | $24K | Hold |
2,538
| – | – | ﹤0.01% | 3660 |
|
|
2015
Q4 | $32K | Hold |
2,538
| – | – | ﹤0.01% | 3632 |
|
|
2015
Q3 | $31K | Hold |
2,538
| – | – | ﹤0.01% | 3621 |
|
|
2015
Q2 | $45K | Sell |
2,538
-30
| -1% | -$540 | ﹤0.01% | 3604 |
|
|
2015
Q1 | $36K | Hold |
2,568
| – | – | ﹤0.01% | 3600 |
|
|
2014
Q4 | $20K | Sell |
2,568
-280
| -10% | -$2.56K | ﹤0.01% | 3650 |
|
|
2014
Q3 | $31K | Hold |
2,848
| – | – | ﹤0.01% | 3611 |
|
|
2014
Q2 | $53K | Sell |
2,848
-73,067
| -96% | -$950K | ﹤0.01% | 3535 |
|
|
2014
Q1 | $1.13M | Buy |
75,915
+1,831
| +2% | +$32.9K | ﹤0.01% | 3237 |
|
|
2013
Q4 | $1.36M | Sell |
74,084
-1,704
| -2% | -$34.1K | ﹤0.01% | 3196 |
|
|
2013
Q3 | $1.57M | Buy |
75,788
+2,267
| +3% | +$51.9K | ﹤0.01% | 3133 |
|
|
2013
Q2 | $1.84M | Buy |
+73,521
| New | +$3.14M | ﹤0.01% | 3017 |
|
State Street's AVEO Position: Q1 2023 in Review
State Street sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 127,282 shares — an estimated $1.9M sold.
State Street first reported a position in AVEO in Q2 2013 and held it in 38 quarters. The position peaked at $5.3M in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- State Street reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- State Street sold 127,282 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.9M.
- State Street first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 38 quarters.
- State Street's AVEO Pharmaceuticals, Inc. position peaked at $5.3M in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.